New Zealand reports death of woman after Pfizer COVID-19 vaccine – .

New Zealand reports death of woman after Pfizer COVID-19 vaccine – .

WELLINGTON – New Zealand has reported its first recorded death from U.S. drug maker Pfizer’s COVID-19 vaccine, the Department of Health said on Monday, after a woman suffered a rare side effect leading to muscle inflammation cardiac.

The report comes as the country battles an outbreak of the Delta variant after nearly six months virus-free. It followed a review by an independent expert group monitoring vaccine safety.

“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the ministry said in a statement, without giving the woman’s age.

The vaccine monitoring panel attributed the death to myocarditis, a rare but known side effect of the Pfizer vaccine, the ministry added.

Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heart rhythms.

Pfizer said it recognizes that there might be rare cases of myocarditis after vaccinations, but that such side effects are extremely rare.

“Pfizer takes the adverse events potentially associated with our vaccine very seriously,” he told Reuters.

“We are closely monitoring all of these events and collecting relevant information to share with global regulatory authorities. “

The health ministry said other medical issues at the same time could have influenced the outcome after the vaccination.

But the benefits of the vaccine outweighed the risks of side effects, he added.

“The benefits of vaccination with the Pfizer COVID-19 vaccine continue to far outweigh the risk of COVID-19 infection and the side effects of the vaccine, including myocarditis. “

Regulators from the United States, the European Union and the World Health Organization have said mRNA vaccines from Pfizer and its partner BioNTech and Moderna are associated with rare cases of inflammation of the heart muscle or the lining around the heart, but the benefits outweigh any risks.

The cases, mostly affecting younger men, tend to be mild and can be treated, but can lead to serious illness, the WHO said.

The European medicines regulator said on July 9 that five people had died of side effects after receiving one of two mRNA vaccines in the European Economic Area, all elderly or suffering from other illnesses. Over 200 million doses of mRNA have been administered in the region.

New Zealand has provisionally approved the use of the Pfizer / BioNTech, Janssen and AstraZeneca vaccines, but only the vaccine produced by Pfizer has been approved for public release.

Monday’s 53 new cases brought New Zealand’s infections in the current outbreak to 562, as part of a nationwide lockdown enforced this month to limit the spread of the Delta variant.


Please enter your comment!
Please enter your name here